For generations, autism has resisted simple definition, presenting so differently across individuals that its very unity as a diagnosis has been questioned. Now, an international team of neuroscientists has offered a partial answer: using brain imaging and mouse models as complementary lenses, they have identified two biologically distinct subtypes of autism — one marked by heightened brain connectivity tied to immune pathways, another by diminished connectivity rooted in synaptic function. The discovery does not resolve the full complexity of autism, but it transforms a long-observed clinical
Medical Xpress
· May 29, 2026
· health
· 6 min read
High
Sourcing: Verified
Brain scans reveal two distinct autism subtypes with different biological origins
◉
Science & Space
8246 related articles
NASA Launches Artemis II: Four Astronauts Head to Moon in Historic Mis…
Devdiscourse · 100% match
Canadian astronaut Kutryk assigned to ISS mission after Starliner dela…
Google News · 99% match
Artemis 3 core stage arrives in Florida ahead of late 2027 lunar missi…
Google News · 99% match
Artemis III Core Rocket Stage Arrives at Kennedy for Late 2027 Launch
Google News · 99% match
SpaceX launches tissue chips and organoids to ISS for groundbreaking s…
Space.com · 99% match
Related Coverage
The Transmitter · Sep 22
Distinct neuron types in autism model show opposing effects on social behavior
Research identifies two distinct neuron populations in the nucleus accumbens that oppositely regulate social behavior in…
sciencedaily.com · Sep 22 Brain scans reveal dopamine damage may explain long COVID fatigue and brain fogResearchers using PET brain scans found that long COVID damages dopamine-releasing neurons, potentially explaining fatig…
ScienceDaily · Sep 22 Scientists identify first new penguin species in 100+ years on remote Kerguelen IslandsGenetic analysis reveals four distinct gentoo penguin species, including one previously unknown population on remote Ker…
News-Medical · Sep 22 Polystyrene nanoplastics linked to reproductive harm and developmental risksA comprehensive review of 114 peer-reviewed studies finds polystyrene nanoplastics may damage reproductive systems in ma…
Bias & Framing
⚖
Article presents research on autism subtypes with neutral, science-focused framing; minimal bias detected in reporting of peer-reviewed findings.
Bias Direction
center
Confidence
HIGH
Straightforward scientific reporting emphasizing research methodology, institutional credibility, and potential clinical applications without sensationalism or advocacy framing.
Autistic self-advocacy perspectives on subtyping approaches
Critiques of biological reductionism in autism research
Concerns about potential misuse of subtyping for discrimination
Diverse voices from autism community on personalized medicine implications
Alternative theoretical frameworks for understanding autism variability
Geopolitical Impact
🌎
Medical research identifying autism subtypes has no direct geopolitical implications; it represents collaborative science between Italian and US institutions advancing healthcare.
Escalation Risk
low
Confidence
HIGH
This is a scientific collaboration article with no geopolitical content. International research cooperation between Italy and the US demonstrates continued academic partnership.
Economic Lens
📈
Research identifying two autism subtypes with distinct brain connectivity patterns creates foundation for personalized diagnostic and therapeutic markets, potentially expanding precision medicine and biotech sectors.
Market Signal
bullish
Confidence
MED
Biotechnology and pharmaceutical development
Medical diagnostics and imaging
Healthcare services and treatment
Mental health and behavioral therapy
Medical device manufacturing
Clinical research and CROs
Individuals with autism and families may benefit from more targeted, effective treatments tailored to specific subtypes, potentially reducing trial-and-error medication approaches and improving outcomes. However, access may depend on availability of advanced brain imaging (fMRI) and specialized diagnostic services.
Regulatory bodies may need to establish new diagnostic criteria and approval pathways for subtype-specific treatments. Healthcare systems may require investment in neuroimaging infrastructure and specialist training. Insurance coverage policies may evolve to support precision diagnostic testing and personalized interventions.